Gram Research analysis shows that people with elevated vitamin B12 levels in their blood are significantly more likely to have cancer. A 2026 South African cohort study of 1,561 patients found that those with high B12 concentrations had a 1.84 times greater risk of malignancy, with risk increasing to 3.12 times higher for very elevated levels. This association held true even after accounting for kidney and liver disease, suggesting high B12 should prompt doctors to investigate for possible cancer.

Researchers in South Africa discovered that unusually high levels of vitamin B12 in the blood may be an early warning sign of cancer. In a study of over 1,500 hospital patients, those with elevated B12 levels were nearly twice as likely to have cancer compared to those with normal levels. The connection was even stronger for very high B12 levels and solid tumors like lung or colon cancer. While B12 is essential for health, abnormally high amounts in your blood, especially without taking supplements, could indicate your doctor should investigate further for possible malignancy.

Key Statistics

A 2026 cohort study of 1,561 South African hospital patients found that those with elevated serum B12 levels had a 1.84 times higher risk of cancer compared to those with normal levels.

According to research reviewed by Gram, patients with very high B12 concentrations (1000-1467 pmol/L) had a 3.12 times increased risk of malignancy in the same 2026 study.

The 2026 South African cohort study found that elevated B12 concentrations were associated with a 2.07 times higher risk of solid tumors specifically, such as lung and colon cancers.

Among 1,561 patients in the 2026 study, elevated B12 was more common in males and individuals with kidney or liver impairment, with statistical significance of p < 0.001.

The Quick Take

  • What they studied: Whether people with unusually high vitamin B12 levels in their blood are more likely to have cancer
  • Who participated: 1,561 patients admitted to a hospital in South Africa between 2017 and 2019. About half had normal B12 levels (791 people) and half had elevated levels (770 people)
  • Key finding: People with high B12 levels were 1.84 times more likely to have cancer. For very high levels (1000-1467 pmol/L), the risk jumped to 3.12 times higher. The association was strongest for solid tumors like lung and colon cancer
  • What it means for you: If your blood test shows unusually high B12 levels and you’re not taking B12 supplements, your doctor should consider screening you for cancer. This is especially important if your levels are very elevated. However, high B12 alone doesn’t mean you have cancer, just that it warrants further investigation

The Research Details

Researchers looked back at medical records from a South African hospital over a five-year period to see how often doctors ordered B12 blood tests and why. They then focused on 1,561 patients tested between 2017 and 2019, dividing them into two groups: those with normal B12 levels (145-569 pmol/L) and those with elevated levels (above 569 pmol/L). They followed these patients for three years after their B12 test to see who developed cancer.

The researchers used statistical methods to account for other factors that might affect B12 levels, such as kidney disease, liver disease, and whether patients were taking B12 supplements. This helped them determine whether high B12 was truly connected to cancer or just a coincidence. They specifically looked for cancers that were confirmed by tissue samples or cell samples under a microscope, not just suspected cancers.

This type of study is valuable because it uses real-world patient data rather than controlled laboratory experiments. It can reveal patterns and associations that doctors might not notice in everyday practice, helping them know when to be more suspicious of underlying disease.

B12 is normally measured to diagnose deficiency, which causes anemia and nerve problems. But doctors rarely think about what high B12 means. This study suggests that elevated B12 should be a red flag for doctors to investigate cancer, particularly in patients not taking B12 supplements. Understanding these warning signs could lead to earlier cancer detection when treatment is often more effective.

This study used actual patient records from a real hospital, which makes the findings relevant to actual medical practice. The sample size was large (1,561 patients), which increases confidence in the results. The researchers adjusted their analysis for other conditions that affect B12 levels, making the cancer connection more reliable. However, the study was conducted in one hospital in South Africa, so results may not apply equally to all populations. The study also couldn’t prove that high B12 causes cancer, only that the two are associated.

What the Results Show

Among the 1,561 patients studied, those with elevated B12 levels had a 1.84 times higher risk of having cancer compared to those with normal levels. This means if the normal group had a certain cancer rate, the elevated group’s rate would be nearly double. The association was statistically significant, meaning it was unlikely to be due to chance alone.

When researchers looked at very high B12 levels (between 1000 and 1467 pmol/L), the cancer risk jumped dramatically to 3.12 times higher. This suggests that the higher the B12 level, the stronger the connection to cancer. For solid tumors specifically (cancers in organs like the lungs, colon, or breast), the risk was 2.07 times higher in the elevated B12 group.

Interestingly, elevated B12 was more common in men than women, and also more common in people with kidney or liver disease. However, even after accounting for these other conditions, the connection between high B12 and cancer remained strong and independent. This suggests that high B12 is a separate warning sign for cancer, not just a side effect of kidney or liver problems.

The study found that elevated B12 concentrations were more frequently observed in males and in individuals with kidney or liver impairment. These associations were statistically significant (p < 0.001), meaning they were very unlikely to occur by chance. The researchers also noted that the pattern held true even when they adjusted their analysis for these other conditions, suggesting that high B12 provides additional information beyond what kidney or liver disease alone would predict.

Previous research has suggested that elevated B12 might be associated with cancer, kidney disease, and liver disease, but studies in African populations have been limited. This South African study provides important new evidence in a population where such data was previously scarce. The findings align with international research suggesting that B12 levels should be interpreted carefully, with both very low and very high levels potentially indicating underlying disease rather than good health.

The study was conducted at a single hospital in South Africa, so the results may not apply equally to other populations or geographic regions. The researchers could only follow patients for three years after their B12 test, so they may have missed cancers that developed later. The study couldn’t prove that high B12 causes cancer, only that the two are associated. Additionally, the study didn’t include information about patients’ diets, alcohol use, or smoking status, which could affect both B12 levels and cancer risk. Finally, the study excluded patients taking B12 supplements, so the findings may not apply to people actively supplementing with B12.

The Bottom Line

If your blood test shows elevated B12 levels and you’re not taking B12 supplements, discuss this with your doctor. Your doctor may recommend cancer screening, especially if your B12 levels are very high or if you have other risk factors for cancer. This is a moderate-strength recommendation based on this study, though more research in different populations would strengthen the evidence. Do not stop taking B12 supplements based on this research without consulting your healthcare provider.

This finding is most relevant for people in South Africa and similar populations who have unexpectedly high B12 levels on blood tests. It’s particularly important for those not taking B12 supplements, as the study specifically excluded supplement users. People with kidney or liver disease should be especially aware, as they showed higher B12 levels in this study. Healthcare providers should also take note, as this research suggests B12 levels deserve more clinical attention than they currently receive.

If elevated B12 is truly a warning sign for cancer, cancers might be detected within weeks to months of discovering high B12 levels through appropriate screening. However, this study followed patients for three years, so some cancers may take longer to develop or become detectable. The benefit of knowing about this association is that it prompts earlier investigation rather than waiting for cancer symptoms to appear.

Frequently Asked Questions

Does high vitamin B12 mean I have cancer?

High B12 doesn’t automatically mean you have cancer, but it’s a warning sign that warrants investigation. In the 2026 study, people with elevated B12 were 1.84 times more likely to have cancer, but many people with high B12 don’t have cancer. Your doctor should evaluate your individual situation.

Should I get screened for cancer if my B12 is high?

If your B12 test shows elevated levels and you’re not taking supplements, discuss cancer screening with your doctor. The 2026 research suggests this is reasonable, especially if your levels are very high (above 1000 pmol/L) or if you have other cancer risk factors.

Can taking B12 supplements cause high levels and cancer risk?

This study specifically excluded people taking B12 supplements, so it doesn’t address supplement use. The cancer association was found in people with naturally elevated B12, not from supplementation. If you take supplements, discuss your B12 levels with your doctor.

What B12 level is considered dangerously high?

In this study, levels above 569 pmol/L were considered elevated and associated with increased cancer risk. Very high levels (1000-1467 pmol/L) showed even stronger associations. Ask your doctor what your specific number means and whether it warrants further investigation.

Is this finding true for all populations or just South Africa?

This study was conducted in South Africa, so results may not apply equally to all populations. More research in different geographic regions would help confirm whether this B12-cancer association is universal or specific to certain groups.

Want to Apply This Research?

  • Log your B12 blood test results when available, noting the specific number (pmol/L) and date. Set a reminder to discuss results with your doctor if levels exceed 569 pmol/L, especially if you’re not supplementing
  • Request B12 testing as part of routine blood work, and ask your doctor to explain what your specific number means. If elevated, ask about cancer screening recommendations appropriate for your age and risk factors
  • Track B12 test results over time in your health app. If levels remain elevated or increase, flag this for discussion at your next doctor visit. Note any new symptoms or health changes between tests

This research suggests an association between elevated B12 levels and cancer risk, but association does not prove causation. High B12 alone does not diagnose cancer. This information is for educational purposes and should not replace professional medical advice. If you have elevated B12 levels on blood tests, consult with your healthcare provider about appropriate screening and follow-up. Do not make changes to any B12 supplementation or cancer screening without discussing with your doctor. This study was conducted in a South African population and may not apply equally to all groups.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Association between elevated serum cobalamin concentrations and malignancy: a retrospective cohort study from the western Cape, South Africa. , Clinical biochemistry (2026). PubMed 42829093 | DOI
Topics
vitamin B12 cancer risk elevated cobalamin malignancy B12 blood test warning signs high B12 levels health cancer screening indicators serum cobalamin association B12 and solid tumors cancer detection early warning